Studies have indicated that the reduction in PEDF levels is negatively associated with the occurrence and progression of diabetic nephropathy, diabetic retinopathy, and the stability of coronary artery plaques, particularly in patients with chronic kidney disease facing an elevated risk of mortality. Here, SERPINF1 is linked to diabetic retinopathy.